Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE2
Sponsor: Sun Yat-sen University
Condition: Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma (NHL)
NCT03245905
Study of Chidamide as a Single-agent Treatment for Patients With Relapse or Refractory B-NHL
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.